We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Test Predicts Preeclampsia Risk in Pregnant Women

By LabMedica International staff writers
Posted on 19 Dec 2013
Print article
Image: Triage Placental Growth Factor (PlGF) Test (Photo courtesy of Alere).
Image: Triage Placental Growth Factor (PlGF) Test (Photo courtesy of Alere).
The diagnosis of preeclampsia by using blood pressure and proteinuria is of limited use because they are tertiary, downstream features of the disease.

Placental growth factor (PlGF) is an angiogenic factor, a secondary marker of associated placental dysfunction in preeclampsia, with known low plasma concentrations in the disease.

In a prospective multicenter study, scientists at King’s College London (UK) studied the diagnostic accuracy of low plasma PlGF concentration in women presenting with suspected preeclampsia between 20 and 35 weeks’ gestation and up to 41 weeks’ gestation as a secondary analysis. Between January 2011 and February 2012, 649 women were recruited.

Plasma samples were tested, using the Triage PlGF Test (Alere; San Diego, CA, USA), at each study center. The assay uses fluorescently labeled recombinant murine monoclonal antibodies and detects PlGF specifically and quantitatively, in the range of 12 to 3,000 pg/mL, in about 15 minutes. In a normal pregnancy, the PIGF levels range from about 100 to 3,000 pg/mL and do not decrease during pregnancy.

The investigators said they could accurately predict the mother would develop preeclampsia if the protein levels were below 100 pg/mL. They also found that if a woman's PlGF levels fell below that threshold before her 35th week of pregnancy, her baby was likely to be delivered within two weeks, and about 61% developed preeclampsia.

Lucy C. Chappell, PhD, the senior author of the study said, “The test is designed to differentiate women with preeclampsia from those with high blood pressure alone. Current tests for the condition only detect that it's happening, rather than predicting it, and by that time the disease has progressed and has likely already caused organ damage. If you have very low levels of this protein called placental growth factor, it reflects the fact that your placenta is not growing well, and that is at the heart of the disease.” The study was published in the November 4, 2013, in the journal Circulation.

Related Links:

King’s College London
Alere


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Tabletop Centrifuge
Mikro 185
New
Hepatitis B Virus Test
HBs Ab – ELISA

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.